“Zombie companies” may do little harm to the US economy
Fears that the US is being overrun by corporate zombies may be exaggerated.

Fears that the US is being overrun by corporate zombies may be exaggerated, says Alexandra Scaggs in Barron’s. Many analysts have argued that the US Federal Reserve’s decision to buy junk bonds (debt with a higher risk of default) during the crisis last year helped prop up companies that should have been allowed to fail. “Heavily indebted, cash-strapped firms” have been able to stagger on, “only surviving because of low interest rates”, say critics. Yet the data doesn’t necessarily suggest this is true.
The value of outstanding bonds from firms that don’t currently earn enough to cover their interest costs and aren’t early-stage growth businesses where profits should rise was $30bn at the end of 2020, down from $70bn in 2019, reckons Michael Puempel of Goldman Sachs. Much of the drop was due to struggling firms going bust, implying the pandemic wiped out old zombies rather than creating new ones.
Of course, today’s low rates might still be making firms that could not have covered their interest in 2019 look better, says Tracy Alloway on Bloomberg. But again that’s not obvious: just 17 US junk-bond issuers are expected to be less profitable in 2022 than in 2019, reckons Martin Fridson of Lehmann Livian Fridson Advisors. “It’s true that companies that look viable right now might not necessarily survive the next downturn,” concludes Alloway. But that doesn’t mean there’s harm in them getting a chance to turn things around.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
HMRC confirms crypto ETN ISA rules
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch for
Wine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
-
The Palace of Westminster is falling down
The Palace of Westminster is in need of repair, but the bill is prohibitive, says Simon Wilson
-
'Gen Z is facing an AI jobs bloodbath'
Opinion It has always been tough to get your first job, but this year, it's proving tougher than ever. AI is to blame, says Matthew Lynn
-
Should the Online Safety Act survive?
The Online Safety Act, a measure to safeguard children, is having unintended consequences
-
The secret behind Sweden’s success
Opinion Sweden's stock market is in rude health, says Max King. Why can't Britain follow suit?
-
Prabowo Subianto: Indonesia’s Deng Xiaoping
Prabowo Subianto, like his Chinese hero, is taking power in his 70s with big ambitions for his country. Yet many view his return to politics with dread